Cencora Inc’s filing revealed that its Officer Mauch Robert P. acquired Company’s shares for reported $1.46 million on Jul 18 ’25. In the deal valued at $294.11 per share,4,968 shares were bought.
Then, COLLIS STEVEN H sold 14,579 shares, generating $4,266,107 in total proceeds. Upon selling the shares at $292.62, the Executive Chairman now owns 311,913 shares.
Before that, COLLIS STEVEN H bought 14,579 shares. Cencora Inc shares valued at $4,266,107 were divested by the Director at a price of $292.62 per share.
Wells Fargo upgraded its Cencora Inc [COR] rating to an Overweight from a an Equal weight in a research note published recently. BofA Securities also remained covering COR and has decreased its forecast on September 18, 2024 with a “Neutral” recommendation from previously “Buy” rating. Leerink Partners started covering the stock on February 26, 2024. It rated COR as “an Outperform”.
Price Performance Review of COR
On Friday, Cencora Inc [NYSE:COR] saw its stock fall -0.51% to $292.87. Over the last five days, the stock has lost -0.79%. Cencora Inc shares have risen nearly 29.94% since the year began. Nevertheless, the stocks have risen 30.35% over the past one year. While a 52-week high of $309.35 was reached on 05/07/25, a 52-week low of $218.65 was recorded on 01/02/25.
Levels Of Support And Resistance For COR Stock
The 24-hour chart illustrates a support level at 291.35, which if violated will result in even more drops to 289.84. On the upside, there is a resistance level at 294.93. A further resistance level may holdings at 296.99.
How much short interest is there in Cencora Inc?
A steep rise in short interest was recorded in Cencora Inc stocks on 2025-06-13, growing by 0.56 million shares to a total of 6.62 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 6.06 million shares. There was a rise of 8.5%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 03, 2024 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $242 price target.
